perhexiline has been researched along with propranolol in 22 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (45.45) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (9.09) | 29.6817 |
2010's | 9 (40.91) | 24.3611 |
2020's | 1 (4.55) | 2.80 |
Authors | Studies |
---|---|
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Atzpodien, EA; Csato, M; Doessegger, L; Fischer, H; Lenz, B; Schmitt, G; Singer, T | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Cho, YW; Ito, H; Matsukawa, H; Okabe, E; Sakamoto, H | 1 |
Beaughard, M; Cosnier, D; Labrid, C; Piris, P | 1 |
Short, D | 1 |
Horowitz, JD; Mashford, ML | 1 |
Caponnetto, S; Iannetti, M; Masperone, MA; Pastorini, C; Perugini, P | 1 |
Caponnetto, S; Iannetti, M; Masperone, MA; Oriani, G; Pastorini, C; Perugini, P | 1 |
Armstrong, ML; Brand, D; Emmett, AJ; Hodge, JL; Kellaway, GS; Mestitz, P; Reefman, M; Wallace, DC | 1 |
Armstrong, ML | 1 |
Cho, YW; Fujisawa, T; Higashi, H; Ito, H; Okabe, E | 1 |
Hashimoto, K; O'Hara, N; Ono, H | 1 |
Arrivet, E; Bichet, N; Fabre, N; Prenez, A; Roome, NO; Trancard, J; Vericat, JA | 1 |
1 review(s) available for perhexiline and propranolol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for perhexiline and propranolol
Article | Year |
---|---|
[Effects of perhexiline maleate in angina pectoris: preliminary clinical and experimental results of a comparative study].
Topics: Angina Pectoris; Clinical Trials as Topic; Drug Evaluation; Humans; Perhexiline; Piperidines; Placebos; Propranolol | 1975 |
A multicentre trial of perhexiline maleate, beta-blocker and placebo in angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Alanine Transaminase; Angina Pectoris; Aspartate Aminotransferases; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Nitroglycerin; Perhexiline; Placebos; Practolol; Propranolol; Vasodilator Agents | 1974 |
Proceedings: A comparative study of perhexiline, beta-adrenergic blocking agents and placebos in the management of angina pectoris.
Topics: Angina Pectoris; Clinical Trials as Topic; Humans; Perhexiline; Piperidines; Placebos; Practolol; Propranolol; Vasodilator Agents | 1973 |
18 other study(ies) available for perhexiline and propranolol
Article | Year |
---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
In silico assay for assessing phospholipidosis potential of small druglike molecules: training, validation, and refinement using several data sets.
Topics: Animals; Cattle; Cells, Cultured; Computer Simulation; Cornea; Drug-Related Side Effects and Adverse Reactions; Fibroblasts; Lipidoses; Lysosomal Storage Diseases; Models, Molecular; Pharmaceutical Preparations; Phospholipids; Structure-Activity Relationship; Thermodynamics | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Cardiovascular effects of isoproterenol and possible antagonistic actions of propranolol and perhexiline.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Cardiac Output; Dogs; Female; Heart Rate; Hemodynamics; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Perhexiline; Piperidines; Propranolol; Rabbits | 1978 |
Activity of bepridil and other anti-anginals on cardiovascular modifications engendered by conditioned anxiety in the dog.
Topics: Amines; Amiodarone; Angina Pectoris; Animals; Anxiety; Behavior, Animal; Benzylamines; Conditioning, Operant; Dipyridamole; Dogs; Female; Hemodynamics; Humans; Male; Nitroglycerin; Pentaerythritol Tetranitrate; Perhexiline; Propranolol; Pyrrolidines | 1978 |
The management of the patient with angina.
Topics: Angina Pectoris; Anticoagulants; Clofibrate; Coronary Artery Bypass; Diazepam; Digoxin; Humans; Isosorbide Dinitrate; Nitroglycerin; Oxprenolol; Perhexiline; Prenylamine; Propranolol; Verapamil | 1977 |
Perhexiline maleate in the treatment of severe angina pectoris.
Topics: Alprenolol; Angina Pectoris; Drug Therapy, Combination; Electrocardiography; Female; Humans; Male; Middle Aged; Perhexiline; Piperidines; Propranolol | 1979 |
Effects of sustained isometric handgrip on ventricular systolic time intervals in patients with ischemic heart disease. Inotropic state of the left ventricle during treatment with perhexiline maleate and with propranolol.
Topics: Aged; Blood Pressure; Coronary Disease; Electrocardiography; Female; Hand; Heart Rate; Humans; Isometric Contraction; Male; Middle Aged; Perhexiline; Physical Exertion; Piperidines; Placebos; Propranolol | 1977 |
Effects of perhexiline on myocardial phosphorylase activity, myocardial catecholamine content and heart rate.
Topics: Animals; Catecholamines; Heart Rate; Isoproterenol; Male; Myocardium; Norepinephrine; Perhexiline; Phosphorylase Kinase; Piperidines; Propranolol; Rats | 1981 |
Effects of perhexiline on hemodynamics in anesthetized open-chest dogs.
Topics: Anesthesia; Animals; Blood Circulation; Blood Flow Velocity; Blood Pressure; Cardiac Output; Dogs; Dose-Response Relationship, Drug; Female; Heart Rate; Hemodynamics; Male; Norepinephrine; Perhexiline; Phentolamine; Piperidines; Propranolol; Verapamil | 1981 |
A new hepatoma cell line for toxicity testing at repeated doses.
Topics: Acetaminophen; Aspirin; Carcinoma, Hepatocellular; Cell Line, Tumor; Dose-Response Relationship, Drug; Humans; Liver Neoplasms; Perhexiline; Propranolol; Toxicity Tests | 2003 |